Product Images Ticagrelor

This description is not available.*

This is a list of dose regimens for the medication Teagelor (Clopidogrel) in different patient groups. It includes the recommended dosages based on patient age groups and conditions. The text also indicates different dosages for US and Non-US populations. The dosages are listed in milligrams (mg) for various scenarios.*

This text appears to provide information on the recommended interactions and dosing adjustments for different drugs when taken with Ticagrelor (AR-C124910XX). It includes details on interacting drugs such as CYP3A inhibitors, moderate CYP3A4 inducers, and PGP and CYP3A inhibitors, along with specific recommendations for each drug. Dosing adjustments and recommendations to avoid concomitant use with certain medications are also mentioned. Additionally, it contains information on the change relative to reference PK in terms of maximum concentration (Cmax) and area under the curve (AUC).*

This text provides information on the interaction of Ticagrelor with various drugs at different doses. It outlines the mean effect and 90% confidence interval, along with recommendations for dose adjustments when using Ticagrelor in combination with Simvastatin 80mg, Atorvastatin 80mg, Levonorgestrel 0.15mg, Ethinyl Estradiol 0.03mg, Tolbutamide 500mg, Digoxin 0.25mg, and Cyclosporine 600mg. It also shows the change relative to the interacting drug alone.*

This is data detailing various characteristics of a medical study, including overall treatment effects, geographic distribution, planned treatment approaches (invasive vs. medical), early intervention with PCI (percutaneous coronary intervention) after randomization, the incidence of patients undergoing CABG (coronary artery bypass grafting), diabetes history, prior TIA/stroke, use of glycoprotein IIb/IIIa inhibitor, age groups, sex distribution, race distribution, and statistical analysis of treatment outcomes with Ticagrelor and Clopidogrel in different scenarios. The data also includes hazard ratios (HR) with confidence intervals indicating the treatment effect of Ticagrelor compared to Clopidogrel in the study.*

This is a description of Ticagrelor tablets, each containing 90 mg of Ticagrelor. The usual adult dosage information is provided in the package insert. The medication guide should be dispensed to each patient. A warning is given to keep the medication out of reach of children and store it at specific temperatures. The tablets are manufactured by MSN Laboratories in India and distributed by Sigmapharm Laboratories in the USA.*

This is a prescription drug for Ticagrelor in tablet form with a concentration of 90mg per tablet. It is typically prescribed to adults; dosage information can be found in the package insert. The medication should be stored at room temperature and kept out of reach of children. The tablets are manufactured by MSN Laboratories in India and distributed by Sigmapharm Laboratories in the USA. Each prescription contains 180 tablets.*

Each tablet of this medication contains 90 mg of ticagrelor. The usual adult dosage information can be found in the package insert. A warning to keep the medication out of the reach of children is provided. The tablets should be stored at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The medication is manufactured by MSN Laboratories Private Limited in Mahabubnagar, Telangana, India. It is important to dispense the accompanying Medication Guide to each patient. Additional details such as lot number and expiration date are not available in the provided text.*

This is information about Ticagrelor tablets, each containing 60 mg of Ticagrelor. The usual adult dosage and storage instructions are provided. The tablets should be dispensed with the accompanying Medication Guide. The medication should be kept out of reach of children and stored at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The tablets are manufactured by MSN Laboratories Private Limited in India and manufactured for Sigmapharm Laboratories in the USA.*

This text provides information about Ticagrelor tablets, with each tablet containing 60 mg of Ticagrelor. It includes dosage instructions, storage guidelines, and details about the manufacturer. The medication guide should be given to each patient. The tablets are manufactured in India and distributed by Sigmapharm Laboratories in the USA. The lot number and expiration date information are not available in the provided text.*